Zobrazeno 1 - 10
of 16
pro vyhledávání: '"J H, Fechner"'
Autor:
Turan, Kanmaz, John J H, Fechner, Jose, Torrealba, Hyoung Tae, Kim, Yinchen, Dong, Terry D, Oberley, Jacqueline M, Schultz, Debra D, Bloom, Masaaki, Katayama, Wasim, Dar, Judit, Markovits, Walter, Schuler, Huaizhong, Hu, Majed M, Hamawy, Stuart J, Knechtle
Publikováno v:
Transplantation. 77(6)
This study assesses the safety and efficacy of the novel human anti-human CD154 monoclonal antibody ABI793 in rhesus monkeys.Outbred rhesus monkeys were used for renal transplantation from major histocompatibility complex-mismatched donors. Seven rec
Publikováno v:
Immunological reviews. 183
Studies in non-human primates to evaluate tolerance strategies in organ transplantation have led to innovation in human transplantation. The two strategies we have studied in detail in non-human primates are T-cell depletion by anti-CD3 immunotoxin a
Autor:
C S, Cho, L C, Burkly, J H, Fechner, A D, Kirk, T D, Oberley, Y, Dong, K G, Brunner, D, Peters, C N, Tenhoor, K, Nadeau, G, Yagci, N, Ishido, J M, Schultz, M, Tsuchida, M M, Hamawy, S J, Knechtle
Publikováno v:
Transplantation. 72(4)
Several conventional forms of immunosuppression have been shown to antagonize the efficacy of anti-CD154 monoclonal antibody- (mAb) based costimulatory molecule blockade immunotherapy. Our objective was to determine if allograft recipients treated wi
Autor:
J H, Fechner, Y, Dong, X, Hong, K G, Brunner, M, Tsuchida, D, Neville, J, Scharff, F, Lee, T D, Oberley, D, Peters, J M, Schultz, E R, Manthei, M M, Hamawy, S J, Knechtle
Publikováno v:
Transplantation. 72(4)
Anti-CD3 immunotoxin (IT), a T-cell-depleting agent, prolongs survival of renal allografts in a rhesus monkey model without the need for long-term immunosuppression. In this study we sought to further prolong allograft survival by giving short-term c
Publikováno v:
Transplantation. 72(3)
The T-cell receptor (TCR)/CD3 complex is the target of therapeutic strategies aimed at prolonging allograft survival. The immunotoxin FN18-CRM9, composed of the anti-CD3 monoclonal antibody FN18 and the mutated diphtheria toxin CRM9, is useful for pr
Autor:
A S, Lagoo, P J, Buckley, L J, Burchell, D, Peters, J H, Fechner, M, Tsuchida, Y, Dong, X, Hong, K G, Brunner, T D, Oberley, M M, Hamawy, S J, Knechtle
Publikováno v:
Transplantation. 70(6)
In our previously described primate renal allograft model, T cell ablation leads to long-term graft survival. The role of endothelial cell alteration in chronic rejection was examined in our model.Renal transplants were performed in rhesus monkeys us
Autor:
W J, Burlingham, E, Jankowska-Gan, L, DeVito-Haynes, J H, Fechner, K T, Hogan, F H, Claas, A, Mulder, X, Wang, S, Ferrone
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 161(12)
Soluble MHC Ags and anti-Id (anti-anti-MHC) Abs have both been shown to inhibit MHC alloantigen-specific B cell responses in vivo. We hypothesized that some anti-idiotypic Abs function as divalent molecular mimics of soluble HLA alloantigen. To test
Autor:
S J, Knechtle, J H, Fechner, Y, Dong, S, Stavrou, D M, Neville, T, Oberley, P, Buckley, N, Armstrong, K, Rusterholz, X, Hong, M, Tsuchida, M M, Hamawy
Publikováno v:
Surgery. 124(2)
T-lymphocyte depletion 7 days before transplantation with immunotoxin FN 18-CRM9 has resulted in tolerance to subsequent renal allografts. We tested the effect of giving immunotoxin on the day of the transplantation and evaluated its effect on rhesus
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 159(1)
Our purposes were 1) to determine whether direct transfer of cDNA encoding allogeneic MHC class I Ag to the rat thymus would be capable of inducing donor-specific unresponsiveness and 2) to study the immunologic mechanism of this effect. Plasmid DNA
Autor:
J H, Fechner, D J, Vargo, E K, Geissler, C, Graeb, J, Wang, M J, Hanaway, D I, Watkins, M, Piekarczyk, D M, Neville, S J, Knechtle
Publikováno v:
Transplantation. 63(9)
Renal allografts were performed in rhesus monkeys using FN18-CRM9, a potent immunotoxin capable of depleting T cells to less than 1% of baseline levels in blood and lymph nodes, as a preparative agent. We have recently reported that animals pretreate